ERBB2 and breast cancer: In univariate analyses, several factors were associated with a significantly worse prognosis in patients with a LM; namely, older age at diagnosis of BC, older age at diagnosis of BM, HR+/HER2-or TNBC subtypes, higher number of BM, worse ECOG, neurological symptoms at time of CNS metastases diagnosis and ECM at time of BM diagnosis.